Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00062062
What this trial is testing

Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 65
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Looking for participantsNCT06080776
What this trial is testing

SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd. 242
Large-scale testing (Phase 3)Study completedNCT00795340
What this trial is testing

Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 306
Not applicableEnded earlyNCT00424138
What this trial is testing

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

Who this might be right for
Lung Cancer
American College of Radiology Imaging Network 96
Large-scale testing (Phase 3)Looking for participantsNCT06041776
What this trial is testing

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Who this might be right for
Non-Small Cell Lung CancerEGFR Sensitive MutationAdjuvant Therapy
Betta Pharmaceuticals Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT03758287
What this trial is testing

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Who this might be right for
Non-small Cell Lung Cancer
Sunshine Lake Pharma Co., Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT00008333
What this trial is testing

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 59
Testing effectiveness (Phase 2)Study completedNCT05014815
What this trial is testing

Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)Nonsmall Cell Lung Cancer, Stage IIIBNonsmall Cell Lung Cancer, Stage IV
BeiGene 272
Testing effectiveness (Phase 2)Study completedNCT00867009
What this trial is testing

Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 113
Early research (Phase 1)Ended earlyNCT00979576
What this trial is testing

BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Study completedNCT00387374
What this trial is testing

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab

Who this might be right for
Adenosquamous Cell Lung CancerDrug/Agent Toxicity by Tissue/OrganHemoptysis+3 more
National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Ended earlyNCT00234468
What this trial is testing

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Who this might be right for
Non Small Cell Lung Carcinoma
AstraZeneca 490
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256509
What this trial is testing

SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 120
Not applicableLooking for participantsNCT05010109
What this trial is testing

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT00005630
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00231465
What this trial is testing

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 44
Large-scale testing (Phase 3)Study completedNCT00676507
What this trial is testing

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Who this might be right for
Lung NeoplasmCarcinoma Non-small Cell Lung Cancer Stage IIIACarcinoma Non-small Cell Lung Cancer Stage IIIB+1 more
NovaRx Corporation 532
Testing effectiveness (Phase 2)Study completedNCT02176369
What this trial is testing

Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 120
Very early researchStudy completedNCT01781741
What this trial is testing

Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
Roswell Park Cancer Institute 10
Next Page